Compounds > temozolomide
Page last updated: 2024-11-04

temozolomide and Squamous Cell Carcinoma of Head and Neck

temozolomide has been researched along with Squamous Cell Carcinoma of Head and Neck in 1 studies

Squamous Cell Carcinoma of Head and Neck: The most common type of head and neck carcinoma that originates from cells on the surface of the NASAL CAVITY; MOUTH; PARANASAL SINUSES, SALIVARY GLANDS, and LARYNX. Mutations in TNFRSF10B, PTEN, and ING1 genes are associated with this cancer.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Pfau, LC1
Glasow, A1
Seidel, C1
Patties, I1

Other Studies

1 other study available for temozolomide and Squamous Cell Carcinoma of Head and Neck

ArticleYear
Imidazolyl Ethanamide Pentandioic Acid (IEPA) as Potential Radical Scavenger during Tumor Therapy in Human Hematopoietic Stem Cells.
    Molecules (Basel, Switzerland), 2023, Feb-21, Volume: 28, Issue:5

    Topics: Cytokines; Glioblastoma; Head and Neck Neoplasms; Hematopoietic Stem Cells; Humans; Reactive Oxygen

2023